Atlas Trials

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

Clinical trial NCT04092452 · COMPLETED

Trial details

NCT number
NCT04092452
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acne Inversa
Start date
2019-12-02
Primary completion
2022-01-10
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.